Follow
Analia Bortolozzi
Analia Bortolozzi
Dept. Neuroscience and Experimental Therapeutics, IIBB - CSIC, IDIBAPS, CIBERSAM
Verified email at iibb.csic.es - Homepage
Title
Cited by
Cited by
Year
Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex
N Santana, A Bortolozzi, J Serrats, G Mengod, F Artigas
Cerebral cortex 14 (10), 1100-1109, 2004
5362004
Mitofusin 2 in POMC neurons connects ER stress with leptin resistance and energy imbalance
M Schneeberger, MO Dietrich, D Sebastián, M Imbernón, C Castaño, ...
Cell 155 (1), 172-187, 2013
4952013
Co-expression and In Vivo Interaction of Serotonin1A and Serotonin2A Receptors in Pyramidal Neurons of Prefrontal Cortex
M Amargós-Bosch, A Bortolozzi, MV Puig, J Serrats, A Adell, P Celada, ...
Cerebral cortex 14 (3), 281-299, 2004
4252004
Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research
P Celada, A Bortolozzi, F Artigas
CNS drugs 27 (9), 703-716, 2013
3502013
Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action
L Díaz-Mataix, MC Scorza, A Bortolozzi, M Toth, P Celada, F Artigas
Journal of Neuroscience 25 (47), 10831-10843, 2005
3452005
Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis
I Carballo-Carbajal, A Laguna, J Romero-Giménez, T Cuadros, J Bové, ...
Nature communications 10 (1), 973, 2019
2542019
The activation of 5‐HT2A receptors in prefrontal cortex enhances dopaminergic activity
A Bortolozzi, L Díaz‐Mataix, MC Scorza, P Celada, F Artigas
Journal of neurochemistry 95 (6), 1597-1607, 2005
2542005
Strategies for producing faster acting antidepressants
A Adell, E Castro, P Celada, A Bortolozzi, A Pazos, F Artigas
Drug discovery today 10 (8), 578-585, 2005
1782005
Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects
A Bortolozzi, A Castañé, J Semakova, N Santana, G Alvarado, R Cortés, ...
Molecular psychiatry 17 (6), 612-623, 2012
1412012
Selective α-synuclein knockdown in monoamine neurons by intranasal oligonucleotide delivery: potential therapy for Parkinson’s disease
D Alarcón-Arís, A Recasens, M Galofré, I Carballo-Carbajal, N Zacchi, ...
Molecular Therapy 26 (2), 550-567, 2018
1212018
In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain
A Bortolozzi, L Díaz-Mataix, M Toth, P Celada, F Artigas
Psychopharmacology 191, 745-758, 2007
1182007
Lenti‐GDNF gene therapy protects against Alzheimer's disease‐like neuropathology in 3xTg‐AD mice and MC65 cells
S Revilla, S Ursulet, MJ Álvarez‐López, M Castro‐Freire, U Perpiñá, ...
CNS neuroscience & therapeutics 20 (11), 961-972, 2014
1162014
In vivo efflux of serotonin in the dorsal raphe nucleus of 5‐HT1A receptor knockout mice
A Bortolozzi, M Amargós‐Bosch, M Toth, F Artigas, A Adell
Journal of neurochemistry 88 (6), 1373-1379, 2004
1052004
Control of 5-hydroxytryptamine release in the dorsal raphe nucleus by the noradrenergic system in rat brain. Role of α-adrenoceptors
A Bortolozzi, F Artigas
Neuropsychopharmacology 28 (3), 421-434, 2003
1002003
Catecholamine/serotonin interactions: systems thinking for brain function and disease
JG Hensler, F Artigas, A Bortolozzi, LC Daws, P De Deurwaerdère, ...
Advances in pharmacology 68, 167-197, 2013
982013
Acute 5-HT1A autoreceptor knockdown increases antidepressant responses and serotonin release in stressful conditions
A Ferrés-Coy, N Santana, A Castañé, R Cortés, MC Carmona, M Toth, ...
Psychopharmacology 225, 61-74, 2013
942013
Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT1A receptors but not 5-HT2A receptors
A Bortolozzi, M Masana, L Díaz-Mataix, R Cortés, MC Scorza, JA Gingrich, ...
International Journal of Neuropsychopharmacology 13 (10), 1299-1314, 2010
912010
Neuronal apoptosis and reversible motor deficit in dominant‐negative GSK‐3 conditional transgenic mice
R Gómez‐Sintes, F Hernández, A Bortolozzi, F Artigas, J Avila, P Zaratin, ...
The EMBO journal 26 (11), 2743-2754, 2007
902007
Selective enhacement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia
M Masana, A Bortolozzi, F Artigas
International Journal of Neuropsychopharmacology 14 (1), 53-68, 2011
812011
Can we increase speed and efficacy of antidepressant treatments? Part I: general aspects and monoamine-based strategies
F Artigas, A Bortolozzi, P Celada
European Neuropsychopharmacology 28 (4), 445-456, 2018
802018
The system can't perform the operation now. Try again later.
Articles 1–20